首頁 › 膠質母細胞瘤 › 賓夕法尼亞州 › Pittsburgh
Pittsburgh, PA 的 膠質母細胞瘤 臨床試驗
9 項針對 膠質母細胞瘤 的研究正在 Pittsburgh（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
招募中3 期
- Allegheny Health Network, Pittsburgh
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
招募中1/2 期
- UPMC Hillman Cancer Center, Pittsburgh
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
招募中2/3 期
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
招募中1 期
- UPMC Hillman Cancer Center, Pittsburgh
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- UPMC Hillman Cancer Center, Pittsburgh
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
招募中2 期
- University of Pittsburgh Medical Center, Pittsburgh
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
招募中2 期
- UPMC Presbyterian Hospital, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
招募中1 期
- University of Pittsburg Medical Center (UPCM), Pittsburgh
其他城市的 膠質母細胞瘤 試驗
- New York City, NY30 項研究
- Boston, MA28 項研究
- Houston, TX26 項研究
- Los Angeles, CA24 項研究
- Durham, NC20 項研究
- San Francisco, CA17 項研究
- Chicago, IL15 項研究
- Washington, DC15 項研究
- Columbus, OH14 項研究
- Miami, FL14 項研究
- Rochester, MN13 項研究
- Jacksonville, FL13 項研究
Pittsburgh 的其他研究
- 非小細胞肺癌48 項研究
- 癌症（所有類型）41 項研究
- 乳癌39 項研究
- 大腸直腸癌32 項研究
- 轉移性癌症31 項研究
- 黑色素瘤31 項研究
- 卵巢癌30 項研究
- 子宮內膜癌23 項研究
- 前列腺癌23 項研究
- 肺癌23 項研究
- 頭頸部鱗狀細胞癌22 項研究
- 中風22 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。